CONSISTENCY IN EFFICACY OUTCOMES OF ELUXADOLINE-TREATED PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA USING RECENT AND TRADITIONAL ENDPOINTS

Marc J. Zuckerman  1     Leonard S. Dove  2     David A. Andrae  3     J. Michael Davenport  2     Lisa Turner  4     Rocio Lopez     Paul S. Covington    
1 Texas Tech University Health Sciences Center,El Paso,United States
2 Furiex Pharmaceuticals, Inc., an affiliate of Actavis, Inc.,Jersey City,United States
3 Actavis, Inc,Jersey City,United States
4 Furiex Pharmaceuticals, Inc., an affiliate of Actavis,

Conference
UEG Week 2015

Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing